EWTX - Edgewise Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$53.10
DETAILS
HIGH:
$66.00
LOW:
$36.00
MEDIAN:
$52.00
CONSENSUS:
$53.10
UPSIDE:
35.56%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-10-01 | Fox Jonathan C | director | A-Award | 308 | -- | -- |
| 2026-08-12 | Russell Alan J | director, officer: Chief Scientific Officer | M-Exempt | 7,031 | -- | -- |
| 2026-08-12 | Derakhshan Behrad | officer: Chief Business Officer | A-Award | 50,000 | -- | -- |
| 2026-08-12 | Russell Alan J | director, officer: Chief Scientific Officer | M-Exempt | 5,781 | -- | -- |
| 2026-08-12 | Russell Alan J | director, officer: Chief Scientific Officer | SELL | 390 | $44.46 | $17K |
| 2026-08-12 | KOCH KEVIN | director, officer: President and CEO | SELL | 8,782 | $43.64 | $383K |
| 2026-08-12 | MOORE JOHN R | officer: General Counsel | A-Award | 32,500 | -- | -- |
| 2026-08-12 | KOCH KEVIN | director, officer: President and CEO | M-Exempt | 21,875 | -- | -- |
| 2026-08-12 | Derakhshan Behrad | officer: Chief Business Officer | SELL | 304 | $44.50 | $14K |
| 2026-08-12 | KOCH KEVIN | director, officer: President and CEO | M-Exempt | 17,969 | -- | -- |
| 2026-08-12 | Derakhshan Behrad | officer: Chief Business Officer | SELL | 150 | $44.44 | $7K |
| 2026-08-12 | MOORE JOHN R | officer: General Counsel | A-Award | 65,000 | -- | -- |
| 2026-08-12 | Donovan Joanne M. | officer: CMO | SELL | 800 | $44.52 | $36K |
| 2026-08-12 | Derakhshan Behrad | officer: Chief Business Officer | SELL | 2,171 | $43.79 | $95K |
| 2026-08-12 | Derakhshan Behrad | officer: Chief Business Officer | M-Exempt | 5,781 | -- | -- |
| 2026-08-12 | Russell Alan J | director, officer: Chief Scientific Officer | A-Award | 65,000 | -- | -- |
| 2026-08-12 | Donovan Joanne M. | officer: CMO | M-Exempt | 5,781 | -- | -- |
| 2026-08-12 | Derakhshan Behrad | officer: Chief Business Officer | M-Exempt | 7,500 | -- | -- |
| 2026-08-13 | Donovan Joanne M. | officer: CMO | SELL | 2,919 | $43.41 | $127K |
| 2026-08-12 | KOCH KEVIN | director, officer: President and CEO | A-Award | 200,000 | $43.56 | $8.7M |
| 2026-08-12 | KOCH KEVIN | director, officer: President and CEO | A-Award | 100,000 | -- | -- |
| 2026-08-12 | Russell Alan J | director, officer: Chief Scientific Officer | SELL | 3,238 | $43.68 | $141K |
| 2026-08-12 | Russell Alan J | director, officer: Chief Scientific Officer | A-Award | 32,500 | -- | -- |
| 2026-08-12 | Russell Alan J | director, officer: Chief Scientific Officer | SELL | 2,273 | $43.68 | $99K |
| 2026-08-12 | Derakhshan Behrad | officer: Chief Business Officer | SELL | 2,475 | $43.70 | $108K |